Investigator Site 11-134 — Tullahoma, Tennessee

Investigator Site 11-134 is a clinical research site located in Tullahoma, Tennessee, United States 37388.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Investigator Site 11-134 has participated in 1 clinical trials.

Therapeutic areas: Hyperkalemia.

Sponsors: Vifor Pharma, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Tullahoma

Browse all research sites in Tennessee · View every site in Tullahoma

• Tennessee Center for Clinical Trials
• Research Site
• GSK Investigational Site
• Trinity Clinical Research
• Novo Nordisk Investigational Site
• Pediatric Clinical Trials of Tennessee, LLC
• Pediatric Clinical Trials Tullahoma-Site Number:8400062
• Pediatric Clinical Trials, LLC
• Pediatric Clinical Trials Tullahoma Site Number : 8400033
• Pearl Investigative Site
• Pearl Therapeutics Study Site
• Investigational Site Number 840011

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigator Site 11-134?

Investigator Site 11-134 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigator Site 11-134 conducted?

Investigator Site 11-134 has 1 clinical trials on record. Their work covers Hyperkalemia.

Is Investigator Site 11-134 accredited by Crixeo Clinical Trials?

Investigator Site 11-134 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigator Site 11-134?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.